Toll Free: 1-888-928-9744

Ocular Hypertension Global Clinical Trials Review, H1, 2016

Published: Mar 30, 2016 | Pages: 370 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Ocular Hypertension Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, Ocular Hypertension Global Clinical Trials Review, H1, 2016" provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level.
 Table of Contents

Table of Contents
List of Tables
List of Figures

Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Ocular Hypertension
Mar 17, 2016: Aerie Pharmaceuticals Reports Update on Positive Safety Results for Rhopressa QD (netarsudil ophthalmic solution) 0.02%
Mar 03, 2016: Aerie Pharmaceuticals Announces Availability on Its Website of Abstracts to be Presented at the American Glaucoma Society 26th Annual Meeting
Feb 17, 2016: Aerie Pharmaceuticals Reports Positive Rhopressa QD (netarsudil ophthalmic solution) 0.02% 12 Month Interim Safety Results for Rocket 2
Feb 16, 2016: Ocular Therapeutix Announces Phase 3 Clinical Development Plan for OTX-TP, an Innovative Therapy for Glaucoma and Ocular Hypertension
Clinical Trial Profile Snapshots

Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables

Ocular Hypertension Therapeutics, Global, Clinical Trials by Region, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2016*
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2016*
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 


List of Figures

Ocular Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2016*
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2016*
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
GlobalData Methodology

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify